Intelligence desk 12 languages Signal over noise

Ebola Sentinel

Tracking Ebola virus disease outbreaks worldwide. Delivering operational intelligence on case trends, transmission dynamics, vaccine/treatment R&D, and humanitarian response for public health professionals and emergency responders.

From hotspot-level epi curves in North Kivu to vaccine shelf-life reports from CEPI, Ebola Sentinel aggregates the signals that matter for containment and response.

About us
Read latest briefing Explore live feed

Why this desk matters

Curated relevance

Real-time outbreak tracking — aggregated WHO situation reports, ministry bulletins, and lab-confirmed case counts across DRC, Guinea, Uganda, and beyond.

Pattern-aware briefings

Medical countermeasure pipeline — efficacy trial results for Ervebo, Inmazeb, Ebanga, and candidate vaccines, plus regulatory milestones from FDA/EMA and CEPI funding decisions.

Cross-language clarity

Operational logistics for responders — MSF field hospital footprints, GOARN deployment alerts, PHEIC declarations, and health system readiness metrics from Africa CDC and national plans.

Latest Spotlight

Open archive
Assessment of BDBV Diagnostics, PARTNERS Trial, and Outbreak Dynamics in Ituri as of Early July 2026

2026-05-24 21:37 UTC

The provided intelligence does not contain specific data on sustained testing throughput, average turnaround time across ten DRC labs, PARTNERS trial enrollment numbers, pre-EUL vs post-EUL case detection delay or reporting accuracy, or quantitative transmission dynamics for Ituri. Available reports confirm PARTNERS trial opening on 2 July 2026, ongoing community resistance and logistical challenges, and general outbreak figures (906 suspected cases, 223 deaths in DRC as of May 29). Diagnostic EUL has been opened for BDBV nucleic acid tests but no operational throughput metrics are provided.

Want to run a Spotlight on a custom topic?

Run your own

Latest briefing

Open archive
WHO approves first Bundibugyo diagnostic test and begins clinical trial for treatments as outbreak surpasses 1,400 cases in DRC.

2026-07-03 - 2026-07-09 · 7 days

This week marked significant progress in the response to the Bundibugyo virus (BDBV) outbreak in the Democratic Republic of the Congo (DRC) and Uganda. On 2 July 2026, the World Health Organization (WHO) added the first molecular diagnostic test for BDBV to its Emergency Use Listing (EUL), enabling rapid detection of v …

  • • WHO added first BDBV molecular diagnostic test to Emergency Use Listing on 2 July.
  • • PARTNERS trial began enrollment for MBP134 monoclonal antibody and remdesivir treatments.

Recent posts

View all